archive checkmark close collapse download expand facebook google-plus hamburger linkedin more notice portfolio print resizetext rss save search twitter youtube

Currently Browsing:March, 2014

Breaking News: US Economy No Longer #1... Maybe

Breaking News: US Economy No Longer #1... Maybe

5 Min. Forecast By Dave Gonigam
PostedApril 30, 2014

Well, it’s official (sort of)… China will surpass the U.S. as the world’s largest economy this year (maybe)… How is this possible? Well, thanks to one reliable, steadfast and completely trustworthy number, the U.S. will hand over it’s economic crown a full five years ahead of schedule (unless it doesn’t). Dave Gonigam explains…

Watch Your Portfolio Skyrocket from Phase 3 Drug Trials

Watch Your Portfolio Skyrocket from Phase 3 Drug Trials

By Paul Mampilly
PostedApril 30, 2014

A Phase 3 trial is the most expensive and critical part of a drug’s clinical testing cycle. That’s because of the staggering amount of time, effort and brainpower that go into a Phase 3 drug. But once it gets to this level, getting FDA approval can be right around the corner. And that’s when the profits can be enormous. Paul Mampilly has more…

Sound Investments in a Time of New Crisis

Sound Investments in a Time of New Crisis

By Byron King
PostedApril 30, 2014

No crisis exists in a vacuum. Thanks to globalization and technological advancements, world events are now more connected than ever before. But along with every major crisis there exist also serious opportunities… Today, Byron King explores the ongoing situation in Russia and Ukraine and offers one way to play it…

2 Reasons "Public Facts" are Complete Nonsense

2 Reasons "Public Facts" are Complete Nonsense

By Bill Bonner
PostedApril 30, 2014

No one loves democracy more than the politicians in power. But just because you get to vote every now and then doesn’t mean the system works. In fact, the system could be responsible for its fair share of problems. But democracy’s become sacred in the U.S. And almost no one bothers to question it. Bill Bonner has more…

Wait for the Magic Number to Bet Against Small Caps

Wait for the Magic Number to Bet Against Small Caps

By Greg Guenthner
PostedApril 30, 2014

Anyone who actively trades stocks has been exposed to some potentially damaging downside action lately. More importantly, what worked in 2013 is not working right now. Anyone who can’t (or won’t) adjust to changing market conditions will continue to suffer. So how can you trade this shift? Greg Guenthner explains…

When the FDA Plays God, Investors Make a Killing

When the FDA Plays God, Investors Make a Killing

5 Min. Forecast By Dave Gonigam
PostedApril 29, 2014

After the disastrous “fen-phen” debacle, the FDA waited 13 years before it approved another weight loss drug. But when it finally approved Belviq in 2012, a handful of savvy investors made a killing thanks to something called the PDUFA date. Today, Dave Gonigam explains exactly what this date is, and why it’s loaded with profit potential. Read on…

Discovered: Untapped Potential in a $124 Billion Market

Discovered: Untapped Potential in a $124 Billion Market

By Ray Blanco
PostedApril 29, 2014

Cancer research has come a long way in a very short amount of time. But it still has a long way to go. Today, Ray Blanco explains why cancer research could make leaps and bounds in the coming years, and how early investors could make a fortune because of it. Read on…

The Key to Becoming a World-Class Biotech Investor

The Key to Becoming a World-Class Biotech Investor

By Paul Mampilly
PostedApril 29, 2014

Despite what you think, you can be a stock market genius. Individual investors can and should be able to beat the guys on Wall Street. All you need are the few important keys to success. Paul Mampilly, a 25 year self-made Wall Street veteran, shares what you’ll need to rise to the top on your own. Read on…

More Financial Lessons from the Head of the Fed

More Financial Lessons from the Head of the Fed

Extra! By Jim Mosquera
PostedApril 29, 2014

Between spurring job growth and providing price stability, Fed Chairwoman Janet Yellen certainly has her hands full. And thanks to Fed “mission creep” it’s only going to get harder. Today, Jim Mosquera examines the second half of Ms. Yellen’s interview for the documentary Money for Nothing: Inside the Federal Reserve. Read on…

Against the Crowd: Buy Treasurys

Against the Crowd: Buy Treasurys

Laissez Faire By Douglas French
PostedApril 29, 2014

When scientists reach a consensus about something, it usually means they’re breaking new ground on a theory based on hard facts and proven evidence. When economists agree on something, it shows the limitations of a field that tries to model how humans are supposed to behave. And that’s where the danger lies. Doug French explores…